Molecular Pharmacology and Psychiatry Mayo Clinic College of Medicine
References
Anton RF, Oroszi G, O’Malley S, Couper D, Swift R, Pettinati H, Goldman D (2008) An evaluation of mu-opioid receptor (OPRM1) as a predictor of naltrexone response in the treatment of alcohol dependence: results from the Combined Pharmacotherapies and Behavioral Interventions for Alcohol Dependence (COMBINE) study. Arch Gen Psychiatry 65: 135-144.[WoS]
Choi DS, Karpyak VM, Frye MA, Hal-Flavin DK, Mrazek DA (2009) Drug Addiction. In: Pharmacology and Therapeutics: Principles to Practice (Waldman SA, Terzic A eds), pp 817-835: Bermedica Production, Ltd.
Collins PY et al. (2011) Grand challenges in global mental health. Nature 475:27-30. [WoS]
Crabbe JC (2002) Genetic contributions to addiction. Annu Rev Psychol 53:435-462.
Kalivas PW, Peters J, Knackstedt L (2006) Animal models and brain circuits in drug addiction. Mol Interv 6:339-344. [Crossref][PubMed]
Meyer-Lindenberg A, Weinberger DR (2006) Intermediate phenotypes and genetic mechanisms of psychiatric disorders. Nat Rev Neurosci 7:818-827.[Crossref]
Nestler EJ, Hyman SE (2010) Animal models of neuropsychiatric disorders. Nat Neurosci 13:1161-1169.
Niculescu AB, Le-Niculescu H (2010) Convergent Functional Genomics: what we have learned and can learn about genes, pathways, and mechanisms. Neuropsychopharmacology 35:355-356.[WoS]
Nutt DJ, King LA, Phillips LD (2010) Drug harms in the UK: a multicriteria decision analysis. Lancet 376:1558-1565.[WoS]
Pouletty P (2002) Drug addictions: towards socially accepted and medically treatable diseases. Nat Rev Drug Discov 1:731-736.
Robison AJ, Nestler EJ (2011) Transcriptional and epigenetic mechanisms of addiction. Nat Rev Neurosci 12:623-637.[WoS]
Spanagel R, Heilig M (2005) Addiction and its brain science. Addiction 100:1813-1822.
The ENCODE Project Consortium (2012) An integrated encyclopedia of DNA elements in the human genome. Nat 489:57-74.